This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms
Journal of Hematology & Oncology Open Access 15 July 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Scott LM . The JAK2 exon 12 mutations: a comprehensive review. Am J Hematol 2011; 86: 668–676.
Kjaer L, Westman M, Hasselbalch Riley C, Hogdall E, Weis Bjerrum O, Hasselbalch H . A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden. PLoS ONE 2012; 7: e33100.
Cazzola M . Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosis. Haematologica 2007; 92: 1585–1589.
Kim N, Jinks-Robertson S . Transcription as a source of genome instability. Nat Rev Genet 2012; 13: 204–214.
Wright BE, Reimers JM, Schmidt KH, Reschke DK . Hypermutable bases in the p53 cancer gene are at vulnerable positions in DNA secondary structures. Cancer Res 2002; 62: 5641–5644.
Hoede C, Denamur E, Tenaillon O . Selection acts on DNA secondary structures to decrease transcriptional mutagenesis. PLoS Genet 2006; 2: e176.
Wright BE, Reschke DK, Schmidt KH, Reimers JM, Knight W . Predicting mutation frequencies in stem-loop structures of derepressed genes: implications for evolution. Mol Microbiol 2003; 48: 429–441.
Lippert MJ, Freedman JA, Barber MA, Jinks-Robertson S . Identification of a distinctive mutation spectrum associated with high levels of transcription in yeast. Mol Cell Biol 2004; 24: 4801–4809.
Warf MB, Berglund JA . Role of RNA structure in regulating pre-mRNA splicing. Trends Biochem Sci 2010; 35: 169–178.
Li X, Manley JL . Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 2005; 122: 365–378.
Xiao R, Sun Y, Ding JH, Lin S, Rose DW, Rosenfeld MG et al. Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis. Mol Cell Biol 2007; 27: 5393–5402.
Fnu S, Williamson EA, De Haro LP, Brenneman M, Wray J, Shaheen M et al. Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining. Proc Natl Acad Sci USA 2010; 108: 540–545.
Wu P, Nakano S, Sugimoto N . Temperature dependence of thermodynamic properties for DNA/DNA and RNA/DNA duplex formation. Eur J Biochem 2002; 269: 2821–2830.
Bercovich D, Ganmore I, Scott LM, Wainreb G, Birger Y, Elimelech A et al. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet 2008; 372: 1484–1492.
Olcaydu D, Skoda RC, Looser R, Li S, Cazzola M, Pietra D et al. The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera. Leukemia 2009; 23: 1924–1926.
Acknowledgements
This work was supported by grants from Leukaemia and Lymphoma Research and the Kay Kendall Leukaemia Fund.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Vorechovsky, I., Jones, A. & Cross, N. Why do we see JAK2 exon 12 mutations in myeloproliferative neoplasms?. Leukemia 27, 1930–1932 (2013). https://doi.org/10.1038/leu.2013.85
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.85
This article is cited by
-
The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms
Journal of Hematology & Oncology (2014)